0001209191-21-061525.txt : 20211025 0001209191-21-061525.hdr.sgml : 20211025 20211025170610 ACCESSION NUMBER: 0001209191-21-061525 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211022 FILED AS OF DATE: 20211025 DATE AS OF CHANGE: 20211025 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ashburn Theodore CENTRAL INDEX KEY: 0001627978 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39575 FILM NUMBER: 211344901 MAIL ADDRESS: STREET 1: 1688 WASHINGTON STREET #1 CITY: BOSTON STATE: MA ZIP: 02118 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oncorus, Inc. CENTRAL INDEX KEY: 0001671818 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473779757 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 450 KENDALL STREET STREET 2: 5TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-425-9200 MAIL ADDRESS: STREET 1: 450 KENDALL STREET STREET 2: 5TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-10-22 0 0001671818 Oncorus, Inc. ONCR 0001627978 Ashburn Theodore C/O ONCORUS, INC. 50 HAMPSHIRE STREET, SUITE 401 CAMBRIDGE MA 02139 1 1 0 0 President and CEO Common Stock 2021-10-22 4 M 0 43707 1.81 A 66852 D Employee Stock Option (right to buy) 1.81 2021-10-22 4 M 0 43707 0.00 D 2028-11-13 Common Stock 43707 288268 D Twenty-five percent (25%) of the shares subject to the option vested on July 16, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to the Reporting Person's continued service through each such vesting date. /s/ John McCabe, Attorney-in-Fact 2021-10-25